Which Nation is Main the Race to Vaccinate?

Over 30 percent of Israelis Have received at least one dose of a coronavirus vaccine, a rate that beats any other country. The United States is way back, about 6 percent of residents received a dose of vaccine, and countries in the European Union started even slower.

Proportion of the population of each nation who received at least one dose of vaccine

10

20%

Bahrain

Canada

Denmark

France

Israel

UAE

United Kingdom

US

15th December

January 24th

Note: Includes countries for which data are available.· ·Source: Our world in data

Our World in Data compiled data on countries with a current vaccination campaign from government sources. Many countries, particularly those in developing countries where governments have had difficulty obtaining vaccines, do not yet vaccinate residents.

Most countries use Pfizer-BioNTech or Moderna vaccines, both of which require two doses. Two of the countries with the highest vaccination rates in the world, the United Arab Emirates and Bahrain, also use a vaccine developed by the Chinese company Sinopharm that is not approved for use in the US or the European Union.

The table below shows which countries have vaccinated their residents fastest since their vaccination campaigns began and which have vaccinated the most in the last seven days. It also shows, at current speeds and vaccination levels, how long it will take for at least half of the population in each country to receive at least one dose of a vaccine.

Speed ​​of vaccinations by country

Proportion of the newly vaccinated population per week
country Since the start Last 7 days At this rate, most of the …
Israel 4 weeks
United Arab Emirates 4 weeks
Great Britain

1.4%

3 mos.
Malta

1.1%

1.9%

6 mos.
Turkey

1%

0.6%

18 mos.
United States

1%

1.9%

6 mos.
Denmark

0.8%

0.2%

55 mos.
Ireland

0.8%

1%

11 mos.
Bahrain

0.8%

2.5%

4 mos.
Spain

0.6%

0.7%

16 mos.
Slovenia

0.6%

0.3%

34 mos.
Italy

0.6%

0.2%

59 mos.
Romania

0.6%

1.2%

9 mos.
Lithuania

0.6%

0.3%

39 mos.
Portugal

0.6%

1%

11 mos.
Estonia

0.5%

0.6%

19 mos.
Sweden

0.5%

0.7%

17 mos.
Switzerland

0.5%

1.2%

9 mos.
Austria

0.5%

0.7%

15 mos.
Cyprus

0.5%

N / A

N / A
Czech Republic

0.5%

0.7%

16 mos.
Germany

0.4%

0.5%

23 mos.
Slovakia

0.4%

0.7%

17 mos.
Poland

0.4%

0.5%

23 mos.
Belgium

0.4%

0.6%

20 mos.
Croatia

0.4%

0.6%

20 mos.
Greece

0.4%

0.7%

16 mos.
France

0.4%

0.9%

13 mos.
Canada

0.4%

0.7%

17 mos.
Hungary

0.4%

0.2%

54 mos.
Norway

0.4%

0.5%

23 mos.
Netherlands

0.3%

0.5%

24 mos.
Luxembourg

0.3%

0.6%

18 mos.
Brazil

0.3%

0.3%

41 mos.
Latvia

0.3%

0.2%

67 mos.
Panama

0.3%

0.2%

55 mos.
Saudi Arabia

0.2%

0.4%

29 mos.
Argentina

0.2%

0.1%

165 mos.
Oman

0.1%

N / A

N / A
Mexico

0.1%

0.1%

105 mos.
India

0.1%

0.1%

116 mos.
Bulgaria

0.1%

<0.1%

290 mos.
Chile

0.1%

0.2%

53 mos.

Show everything
show less

Note: Last week prices show the seven-day period from January 17th to January 24th. If values ​​were not available for both dates, the price was calculated based on the closest available date.· ·Source: Our world in data

Israel, for example, will reach half of its population with at least one dose of the vaccine in just four weeks at its current rate, although the vaccination campaign and vaccination rate excludes Palestinians in the occupied West Bank and the blocked Gaza Strip, who may have spent several months on the spread waiting. Most European countries are still months away from Israel’s vaccination levels.

Some of the differences arise from the approval of vaccines in the individual countries. Health officials in the European Union approved the Pfizer vaccine 10 days later than their US counterparts and almost three weeks according to British officials.

In some countries, prevalence lagged even after the vaccine was approved. The Netherlands, one of the richest countries in Europe, was the last in the European Union to launch its vaccination campaign – on January 6, a week and a half after neighboring Germany and almost a month after the United Kingdom. The Dutch Minister of Health attributed the delay to the need for adequate preparation.

The slow adoption of vaccines in Europe has been hampered by supply shortages, a shortage of nurses and tedious paperwork. Criticism of the European Union’s procurement strategy has grown louder as new variants of the virus threaten to gain a foothold on the continent.

The Hungarian authorities recently broke the block to approve the Russian vaccine Sputnik V and the Oxford-AstraZeneca vaccine. Hungary also agreed to buy China’s Sinopharm vaccine.

If Europe moves slowly, almost all the nations in the developing world are further behind, and in most of them the vaccinations have not even started. Wealthy countries have pre-ordered more than half the doses that could hit the market by the end of the year, enough in many cases to vaccinate their populations multiple times. Many poorer nations may be able to vaccinate no more than one in five people by then.

Comments are closed.